Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Pharm ; 11(3): 828-35, 2014 Mar 03.
Article in English | MEDLINE | ID: mdl-24433027

ABSTRACT

Multiple sclerosis (MS) is an autoimmune, demyelinating disease of the central nervous system that can cause loss of motor function and is thought to result, in part, from chronic inflammation due to an antigen-specific T cell immune response. Current treatments suppress the immune system without antigen specificity, increasing the risks of cancer, chronic infection, and other long-term side effects. In this study, we show treatment of experimental autoimmune encephalomyelitis (EAE), a model of MS, by coencapsulating the immunodominant peptide of myelin oligodendrocyte glycoprotein (MOG) with dexamethasone (DXM) into acetalated dextran (Ac-DEX) microparticles (DXM/MOG/MPs) and administering the microparticles subcutaneously. The clinical score of the mice was reduced from 3.4 to 1.6 after 3 injections 3 days apart with the coencapsulated microparticulate formulation (MOG 17.6 µg and DXM 8 µg). This change in clinical score was significantly greater than observed with phosphate-buffered saline (PBS), empty MPs, free DXM and MOG, DXM/MPs, and MOG/MPs. Additionally, treatment with DXM/MOG/MPs significantly inhibited disease-associated cytokine (e.g., IL-17, GM-CSF) expression in splenocytes isolated in treated mice. Here we show a promising approach for the therapeutic treatment of MS using a polymer-based microparticle delivery platform.


Subject(s)
Dexamethasone/administration & dosage , Dextrans/chemistry , Drug Delivery Systems , Encephalomyelitis, Autoimmune, Experimental/therapy , Myelin-Oligodendrocyte Glycoprotein/immunology , Peptide Fragments/administration & dosage , Polymers/chemistry , Animals , Cell Proliferation/drug effects , Combined Modality Therapy , Cytokines/metabolism , Dexamethasone/pharmacokinetics , Encephalomyelitis, Autoimmune, Experimental/immunology , Encephalomyelitis, Autoimmune, Experimental/pathology , Female , Flow Cytometry , Mice , Mice, Inbred C57BL , Myelin-Oligodendrocyte Glycoprotein/metabolism , Nitric Oxide/metabolism , Peptide Fragments/immunology , Tissue Distribution
2.
PLoS One ; 7(10): e48349, 2012.
Article in English | MEDLINE | ID: mdl-23133584

ABSTRACT

Uropathogenic Escherichia coli (UPEC) utilizes a complex community-based developmental pathway for growth within superficial epithelial cells of the bladder during cystitis. Extracellular DNA (eDNA) is a common matrix component of organized bacterial communities. Integration host factor (IHF) is a heterodimeric protein that binds to double-stranded DNA and produces a hairpin bend. IHF-dependent DNA architectural changes act both intrabacterially and extrabacterially to regulate gene expression and community stability, respectively. We demonstrate that both IHF subunits are required for efficient colonization of the bladder, but are dispensable for early colonization of the kidney. The community architecture of the intracellular bacterial communities (IBCs) is quantitatively different in the absence of either IhfA or IhfB in the murine model for human urinary tract infection (UTI). Restoration of Type 1 pili by ectopic production does not restore colonization in the absence of IhfA, but partially compensates in the absence of IhfB. Furthermore, we describe a binding site for IHF that is upstream of the operon that encodes for the P-pilus. Taken together, these data suggest that both IHF and its constituent subunits (independent of the heterodimer), are able to participate in multiple aspects of the UPEC pathogenic lifestyle, and may have utility as a target for treatment of bacterial cystitis.


Subject(s)
Integration Host Factors/genetics , Uropathogenic Escherichia coli/metabolism , Animals , DNA, Bacterial/metabolism , Deoxyribonuclease I/metabolism , Dimerization , Escherichia coli Infections/microbiology , Female , Humans , Kidney/microbiology , Mice , Mice, Inbred C3H , Microscopy, Fluorescence/methods , Models, Genetic , Promoter Regions, Genetic , Urinary Bladder/microbiology , Urinary Tract Infections/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...